Shanty A.A | Biochemistry | Best Researcher Award

Published on by Innovation Technologist

Dr. Shanty A.A | Biochemistry | Best Researcher Award

Assistant Professor at St. Teresa’s College | India

Dr. Shanty Antony Angamaly is an accomplished Assistant Professor at St. Teresa’s College, Ernakulam, specializing in Inorganic Chemistry, Biochemistry, and Analytical Chemistry. She earned her Ph.D. in Bioinorganic Chemistry under the guidance of Dr. P.V. Mohanan, focusing on heterocyclic Schiff bases and their transition metal complexes as versatile pharmacophores. Her research expertise spans inorganic and bioinorganic chemistry, analytical methods, molecular docking, sensor development, and biological assays. She has extensive experience working with modern analytical instruments including UV-Visible, FT-IR, fluorescence, CD spectrometers, GC-MS, LC-MS, and voltammetric techniques. Dr. Shanty has authored several high-impact publications in international peer-reviewed journals, contributing significantly to the fields of metal complexes, DNA binding studies, enzyme inhibition, fluorescence sensors, and computational chemistry. She has presented her research at multiple national and international conferences and received recognition through awards such as the Young Scientist Award, Best Paper Award, and Young Woman Researcher in Chemistry Award. In addition to research, she is an experienced educator, having guided M.Phil. and postgraduate students, and served as a guest lecturer and external examiner. She actively contributes to professional societies as a reviewer, organizes academic and scientific programs, and mentors students in research and professional development, demonstrating a strong commitment to advancing chemistry education and research.

Profile: Google Scholar

Featured Publications

  • Angamaly, A. A., & Mohanan, P. V. (2021). Synthesis, characterization, DNA binding, antibacterial, antidiabetic, molecular docking and DFT studies of Ni(II), Cu(II) and Zn(II) complexes derived from heterocyclic Schiff base. Inorganic and Nano-Metal Chemistry.

  • Gopalakrishnan, A. K., Angamaly, S. A., & Mohanan, P. V. (2021). An insight into the biological properties of imidazole-based Schiff bases: A review. ChemistrySelect.

  • Gopalakrishnan, A. K., Angamaly, S. A., Pradeep, S. D., Madhusoodhanan, D. T., Manoharan, D. K., & Mohanan, P. V. (2021). A novel imidazole bound Schiff base as highly selective “turn-on” fluorescence sensor for Zn²⁺ and colorimetric kit for Co²⁺. Journal of Fluorescence.

  • Shanty, A. A., Raghu, G., & Mohanan, P. V. (2019). Synthesis, characterization, spectral and theoretical, molecular docking and in vitro studies of copper complexes with HIV RT enzyme. Journal of Molecular Structure, 1197, 154–163.

  • Angamaly, A. A., & Mohanan, P. V. (2018). Heterocyclic Schiff bases as non-toxic antioxidants: Solvent effect, structure activity relationship and mechanism of action. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 192, 181–187.

 

 

Dolores Di Vizio | Biochemistry | Best Researcher Award

Published on by Innovation Technologist

Prof. Dr. Dolores Di Vizio | Biochemistry | Best Researcher Award

Professor at Cedars-Sinai Medical Center | United States

Dr. Dolores Di Vizio is a globally recognized physician-scientist whose research has significantly advanced the fields of cancer biology, extracellular vesicles (EVs), and translational oncology. She holds multiple academic positions at Cedars-Sinai Medical Center and plays a leading role in international scientific organizations. Dr. Di Vizio is best known for pioneering the discovery of large oncosomes, a novel type of extracellular vesicle implicated in cancer progression and metastasis.

Publication Profile 

Scopus

Educational Background 

Dr. Di Vizio earned both her M.D. and Ph.D. degrees from the University of Naples Federico II in Italy. Following her graduate education, she completed postdoctoral training at Harvard Medical School, where she honed her expertise in molecular and cancer biology, laying the foundation for her later groundbreaking work in EVs and cancer metastasis.

Professional Experience 

Dr. Di Vizio is a Professor in the Departments of Surgery, Pathology & Laboratory Medicine, and Biomedical Sciences at Cedars-Sinai Medical Center in Los Angeles. She also serves as Co-Director of the Cancer Biology Program at the Samuel Oschin Comprehensive Cancer Institute. Her international presence includes visiting faculty positions at Yonsei University in Korea, the University of Calabria in Italy, and IRCCS Regina Elena in Italy. Prior to her tenure at Cedars-Sinai, she held a faculty position at Harvard Medical School. Her editorial influence is substantial, serving as Deputy Editor of the Journal of Extracellular Vesicles and sitting on the editorial boards of prominent journals such as Oncotarget, Biomedicines, and Frontiers in Oncology. Additionally, she has organized and chaired major scientific conferences including the Gordon Research Conference and the International Society for Extracellular Vesicles (ISEV) meetings in 2021 and 2023.

Research Interests 

Dr. Di Vizio’s research centers on the biology of extracellular vesicles, particularly large oncosomes, and their role in tumor dissemination, with a focus on prostate cancer. She investigates the molecular and cellular mechanisms driving cancer metastasis and signal transduction, including cytoskeletal remodeling and intercellular communication. Her work also emphasizes translational research, with a goal of developing EV-based diagnostic tools and therapeutic strategies for advanced cancers.

Awards and Honors 

Throughout her career, Dr. Di Vizio has secured over $10 million in competitive research funding from prestigious agencies including the National Institutes of Health (NIH), Department of Defense (DoD), Avon Foundation, and the American Italian Cancer Foundation (AICF). She has been an invited speaker at more than 70 national and international institutions and high-profile events, such as Nature Webinars, Keystone Symposia, and AACR meetings. She has also served as a reviewer and panelist for NIH study sections, the DoD Prostate Cancer Program, and the European Research Council (ERC). Her contributions to mentorship and training are equally impressive, with leadership roles in NIH T32, R25, and CTSI-supported programs and mentorship roles in DoD and SPORE-funded initiatives.

Publications 

  1. Title: Extracellular vesicle heterogeneity through the lens of multiomics
    Year: 2025

  2. Title: Roadblocks of Urinary EV Biomarkers: Moving Toward the Clinic
    Year: 2025

  3. Title: Emerin Dysregulation Drives the Very-Small-Nuclear Phenotype and Lineage Plasticity That Associate with a Clinically Aggressive Subtype of Prostate Cancer
    Year: 2025

  4. Title: A class of large cell-like extracellular vesicles: Extracellular vesicles
    Year: 2025
    Citations: 3

  5. Title: Mechanisms governing lineage plasticity and metabolic reprogramming in cancer
    Year: 2025
    Citations: 3

Conclusion 

Dr. Dolores Di Vizio is an internationally respected leader in cancer research whose pioneering contributions to extracellular vesicle biology have reshaped current understanding of tumor progression and metastasis. Her dedication to translational science, strong record of mentorship, and active leadership in global scientific communities position her as a standout figure in contemporary oncology research. She is exceptionally well-qualified for recognition through high-level research awards, embodying a career defined by scientific innovation, educational commitment, and impactful interdisciplinary collaboration.

 

 

 

Celine FABRET | Biology | Best Researcher Award

Published on by Innovation Technologist

Assist. Prof. Dr. Celine FABRET | Biology | Best Researcher Award

Lecturer at Paris-Saclay University, France

Dr. Céline Fabret is a Research Associate Professor at Paris-Saclay University, working at the Institut de Biologie Intégrative de la Cellule (I2BC). She holds a Ph.D. in Molecular Biology and Genetics from Université Aix-Marseille II and has extensive postdoctoral experience in both France and the United States. Her research focuses on translation termination, ribosome rescue mechanisms, prion biology, and gene regulation in bacteria and yeast. With a strong background in genetics and RNA biology, she has contributed to several international genome projects and has published in leading journals. Dr. Fabret is also an experienced educator and mentor, actively involved in training students and participating in academic governance.

Publication Profile 

Scopus

Educational Background 🎓

  • Ph.D. in Molecular Biology and Genetics, Université Aix-Marseille II, France (1996)

    • Doctoral research at CNRS Marseille, within the European-Japanese Bacillus subtilis genome project

  • Master’s in Molecular Biology, Université Aix-Marseille II, France

Professional Experience 💼

  • 2025–Present: Research Associate Professor, Paris-Saclay University, I2BC

  • 2011–Present: Faculty member, Paris-Saclay University (teaching microbiology, genetics, molecular biology, genomics)

  • 2001–2011: Lecturer, Sorbonne University (Pierre et Marie Curie Campus)

  • 1999–2001: Researcher in P. Noirot’s lab at INRA, Jouy-en-Josas – Genetic tools development and essential gene characterization

  • 1998–1999: Researcher in L. Jannière’s lab at INRA – High-frequency in vivo mutagenesis system in E. coli

  • 1996–1998: Postdoctoral Fellow, J.A. Hoch’s Lab, The Scripps Research Institute (La Jolla, USA) – Sporulation and two-component systems in Bacillus subtilis

  • 1991–1996: Doctoral researcher, CNRS Marseille – DNA sequencing and transcriptional analysis in B. subtilis

Research Interests 🔬

Dr. Fabret’s research bridges bacterial and eukaryotic translation, gene regulation, and RNA biology. Her focus includes:

  • Translation termination mechanisms in yeast and bacteria

  • Prion biology and its effect on stop codon recognition ([PSI+] phenotype)

  • Ribosome rescue and RNA quality control systems (RQC2, trans-translation)

  • Antibiotic response and translational reprogramming in Gram-negative bacteria

  • Functional genomics and essential gene analysis in Bacillus subtilis

  • Post-transcriptional modifications and their role in translational fidelity

She has supervised 2 PhD theses, 3 Master 2 (M2), and 16 Master 1 (M1) students, contributing to the training of the next generation of molecular biologists.

Awards and Honors🏆✨

  • Lead participant in multiple European research consortia on genome projects and enzyme engineering

  • Co-author of high-impact publications in Nature Cell Biology, Structure, Nucleic Acids Research, Molecular Microbiology

  • Elected member of the Consultative Commission of Biology Specialists and the Biology Department Council, Paris-Saclay University

  • Recognized for interdisciplinary collaboration with pharmaceutical companies (e.g., Aventis) and international institutions

Conclusion🌟

Dr. Céline Fabret has made sustained and meaningful contributions to molecular microbiology, translation biology, and bacterial physiology. Through a unique combination of genetic, biochemical, and functional genomics approaches, she has deepened our understanding of translation mechanisms and gene regulation across domains of life. As a researcher, educator, and mentor, she remains committed to advancing science and supporting young scientists in their careers.

Publications 📚

  1. 🧬 Fabret C, Giudice E, Chat S, Gillet R, Namy O (2025)
    RQC2 is a major player in peptide release from stalled ribosomes
    Structure, 31: S0969-2126(25)00105-4.

  2. 🦠 Fruchard L, Babosan A, Carvalho A, Lang M, Li B, Duchateau M, Giai Gianetto Q, Matondo M, Bonhomme F, Hatin I, Arbes H, Fabret C, et al. (2025)
    Aminoglycoside tolerance in Vibrio cholerae engages translational reprogramming
    (Accepted, journal not specified).

  3. 🧪 Fabret C, Namy O (2021)
    Translation efficiency of E. coli ribosomes with covalently linked subunits
    Nucleic Acids Research, 49(9): 5308–5318.

  4. 🔬 Malagnac*, Fabret* et al. (2013)
    A gene regulated by a -1 frameshift in Podospora anserina
    PLoS One, 8(9): e73772. (co-first authors)

  5. 🔎 Cosnier B, Kwapisz M, Hatin I, Namy O, Fabret C (2011)
    Translational readthrough of S. cerevisiae genes IMP3 and PDE2
    PLoS One, 6(4): e19500.

  6. 🧫 Desmolaize B, Fabret C, Graille M, van Tilbeurgh H, Brochier-Armanet C, Namy O (2011)
    23S rRNA modifications in Bacillus subtilis
    Nucleic Acids Research, 39(21): 9368–9375.

  7. 🧬 Fabret C, Malagnac F, Namy O (2011)
    tRNA-CAU modification enzyme and AUA codon recognition in Bacillus subtilis
    Molecular Microbiology, 80(4): 1062–1074.

  8. 💡 Blanchet S, Cornu D, Hatin I, Grosjean H, Bertin P, Namy O, Fabret C (2015)
    eRF1 interactions with stop codons and the ribosome
    Nucleic Acids Research, 43(6): 3298–3308.

  9. 🧠 Kabani M, Melki R, Fabret C (2011)
    Prion formation and the eRF3 protein in yeast
    Molecular Microbiology, 81(3): 640–658.

  10. 🔬 Tork S, Hatin I, Rousset JP, Fabret C (2004)
    5′ and 3′ context effects on stop codon recognition
    Nucleic Acids Research, 32(2): 415–421.